• News

    HDA Statement on Federal Trade Commission and Health and Human Services RFI on Drug Shortages

    February 15, 2024

    HDA commented on the release of an FTC and HHS Request for Information (RFI) investigating the causes of drug shortages.

  • News

    HDA Research Foundation Names Apotex and Anda Executives To Lead Board of Directors

    January 17, 2024

    The HDA Research Foundation announced Steve Giuli of Apotex Corp. as Chairman of its Board of Directors. Anthony Mihelich of Anda, Inc., was named Vice Chairman. 

  • News

    HDA Statement on FDA Approval of Florida’s Prescription Drug Importation Plan

    January 05, 2024

    Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released a statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and Cosmetic Act.

  • News

    HDA Statement on Drug Shortages

    December 05, 2023

    Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released the following statement in response to the Senate Finance Committee hearing entitled, “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.”

  • News

    HDA Research Foundation Announces the 2023 Karen J. Ribler Supply Chain Scholars

    November 16, 2023

    The HDA Research Foundation announced four recipients of the Karen J. Ribler Scholarship at its Fifteenth Annual CEO Roundtable Fundraiser in Washington, D.C.

  • News

    Specialty Distributors Continue To Provide Effective Delivery and Value to the U.S. Healthcare Ecosystem

    November 14, 2023

    New benchmarking data released by the HDA Research Foundation showcase the continued value of HDA specialty distributors to the U.S. healthcare ecosystem. As illustrated in the 15th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, the average specialty distributor delivered medicines to treat chronic, complex or rare diseases to 51,469 unique ship-to points in 2022.

Media Contacts

John Parker
Senior Vice President, Communications and Marketing

Farah Simonett
Vice President, Communications and Marketing

Elizabeth Baker
Director, Communications